ADR	Adverse Drug Reaction
AMA	African Medicines Agency
BLA	Biologics License Application
CHMP	Committee for Medicinal Products for Human Use
CIRS	Center for Innovation in Regulatory Science
EUL	Emergency Use Listing
HCT/Ps	Cellular and Tissue-Based Products
CFR	Code of Federal Regulations
IND	Investigational New Drug
DCGI	Drugs Controller General of India
GMP	Good Manufacturing Practice
NDA	New Drug Application
PV	Pharmacovigilance
RA	Regulatory Affairs
REMS	Risk Evaluation and Mitigation Strategy
RMP	Risk Management Plan
RMAT	Regenerative Medicine Advanced Therapy
RWE	Real-World Evidence
WHO	World Health Organization